Palisades Investment Partners Q2 2026 Portfolio Activity: Major Buys and Sells Observed

As part of our ongoing coverage of institutional investor activity, we've analyzed the latest portfolio filing from Palisades Investment Partners Llc, effective as of June 30th, 2026. This filing provides valuable insights into the investment firm's strategic decisions during Q2.

Prominent Purchases Observed in Q2

Several notable purchases were identified by Palisades Investment Partners Llc this quarter based on their portfolio changes. The most significant increase was observed in Willis Lease Finance Corp (WLFC), an Industrials stock, which saw its position grow substantially by 182% compared to the previous period (WLFC). This suggests a strong conviction or perhaps capitalizing on favorable market conditions for this financial services entity.

Additionally, Palisades added new positions with considerable weight. Ichor Holdings (G4740B105), identified in the filing as ICHOR HOLDINGS, was entirely a new holding, contributing 2.87% to the portfolio's allocation at quarter-end.

Across other sectors, Palisades demonstrated active buying. One Stop Systems Inc (OSS), or ONE STOP SYS INC, was added as a new position with 100% increase in shares during the quarter (Palisades Investment Partners Llc). Similarly, POET Technologies Inc (POET) was also added entirely new this period (POET TECHNOLOGIES INC), now holding 1.02% of the portfolio.

The filing indicates that Palisades is actively diversifying its holdings, incorporating companies from different industry segments into its investment strategy for Q2 2026.

Significant Reductions and Exits

In contrast to these additions, the investor also divested substantial portions of certain stocks during the quarter. MEDP (Medpace Holdings Inc), a Healthcare stock, was notably sold out entirely by Palisades Investment Partners Llc (MEDPACE HLDGS INC). This complete exit suggests a strategic shift away from this particular biotech-focused company.

Furthermore, MMYT (Makemytrip Limited Mauritius), identified as MAKEMYTRIP LIMITED MAURITIUS, experienced a significant reduction in its position. The shares held by Palisades decreased by 86.27% during Q2, indicating either an aggressive sell-off or simply the stock being delisted from their portfolio.

Another Technology holding saw substantial share reduction: BMI (Badger Meter Inc), which is BADGER METER INC. Palisades sold off a large portion of this stock, reducing its allocation by 86.74%.

These exits and reductions highlight the firm's dynamic nature, adjusting positions based on performance or strategic realignment during Q2.

Moderate Changes in Existing Holdings

Beyond major additions and subtractions, Palisades Investment Partners Llc also made moderate adjustments to some existing holdings. For instance, SPXC (SPX Technologies Inc), a key Industrials holding, saw an increase of 3.58% (SPX TECHNOLOGIES INC). Similarly, TVTX (TraVere Therapeutics Inc) increased by 6.99%, and PKE (Park Aerospace Corp) saw a modest rise of 4.34%.

On the decrease side, Veracyte Inc (VCYT), another Healthcare stock (VERACYTE INC), experienced a reduction in its portfolio allocation by 2.6% during Q2.

The firm also adjusted positions like CRMD (Cormedix Inc) and ENVA (Enova International Inc). While these changes are less dramatic than the major buys/sells, they reflect ongoing management of the entire investment universe.

Portfolio Structure Insights

The overall portfolio structure as of June 30th shows Palisades Investment Partners Llc heavily weighted towards Industrials (34.0%) and Technology (27.63%). Healthcare follows closely at 17.98%, while Financial Services accounts for a solid 12.49% allocation.

The remaining allocations are relatively smaller, with Utilities at 1.79%, Real Estate at 0.6%, Consumer Cyclical at 1.45%, and sectors categorized as Unknown or Basic Materials making up the rest (3.36% + 0.7%).